Company · CIK 0001088856 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
CORCEPT THERAPEUTICS INC · CORT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 7:47 pm EDT | Gary Charles RobbChief Business Officer | 17,493 | $8.27 | $144,667 | 31,156 | — | |
| Sep 16, 2026 SForm 4 → | Sep 18, 7:53 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 296 | $100.82 | $29,843 | 3,946 | −6.98% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:30 pm EDT | James N WilsonDirector | 10,000 | $110.69 | $1,106,940 | 1,064,543 | −0.93% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 4:30 pm EDT | Joseph Douglas LyonSee Remarks | 10,000 | $113.49 | $1,134,947 | 5,683 | −63.8% | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 16, 4:30 pm EDT | Joseph Douglas LyonSee Remarks | 10,000 | $12.99 | $129,863 | 15,683 | — | 10b5-1 |
| Sep 2, 2026 SForm 4 → | Sep 3, 9:02 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 58,333 | $110.76 | $6,460,766 | 4,242 | −93.2% | 10b5-1 |
| Sep 1, 2026 AForm 4 → | Sep 3, 9:16 pm EDT | William GuyerChief Development Officer | 328 | $113.38 | $18,594 | 4,313 | — | |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:16 pm EDT | Sean MaduckSee Remarks | 25,000 | $114.43 | $2,860,737 | 9,755 | −71.9% | 10b5-1 |
| Sep 1, 2026 AFMForm 4 → | Sep 3, 9:16 pm EDT | Sean MaduckSee Remarks | 25,417 | $9.38 | $237,022 | 9,938 | — | 10b5-1 |
| Sep 1, 2026 AFForm 4 → | Sep 3, 9:06 pm EDT | Atabak MokariChief Financial Officer | 378 | $113.38 | $27,211 | 16,304 | — | |
| Sep 1, 2026 AFForm 4 → | Sep 3, 9:03 pm EDT | Gary Charles RobbChief Business Officer | 419 | $113.38 | $28,912 | 13,663 | — | |
| Sep 1, 2026 AFMForm 4 → | Sep 3, 9:02 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 58,711 | $22.01 | $1,288,954 | 62,575 | — | 10b5-1 |
| Sep 1, 2026 AFForm 4 → | Sep 3, 9:00 pm EDT | Joseph Douglas LyonSee Remarks | 332 | $113.38 | $22,903 | 5,683 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 7:47 pm EDT | Gary Charles RobbChief Business Officer | 17,493 | — | — | 182,507 | — | |
| Sep 14, 2026 MForm 4 → | Sep 16, 4:30 pm EDT | Joseph Douglas LyonSee Remarks | 10,000 | — | — | 4,167 | — | 10b5-1 |
| Sep 2, 2026 MForm 4 → | Sep 3, 9:02 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 58,333 | — | — | 141,667 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 9:16 pm EDT | Sean MaduckSee Remarks | 25,000 | — | — | 66,986 | — | 10b5-1 |